Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Capital Reinvestment Ratio
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Capital Reinvestment Ratio of 1.44x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥21.03 Million) in capital expenditures (CN¥30.36 Million). See Shanghai Yizhong Pharmaceutical Co Ltd (688091) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Yizhong Pharmaceutical Co Ltd Capital Reinvestment Ratio (2022–2024)
This chart tracks Shanghai Yizhong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 3 annual periods. Check Shanghai Yizhong Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shanghai Yizhong Pharmaceutical Co Ltd (2022–2024)
Year-by-year Capital Reinvestment Ratio for Shanghai Yizhong Pharmaceutical Co Ltd from 2022 to 2024. For live market cap and broader valuation context, see Shanghai Yizhong Pharmaceutical Co Ltd (688091) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.03x | CN¥39.44 Million | CN¥80.04 Million | ▲ +1900.3% |
| 2023 | 0.10x | CN¥86.55 Million | CN¥8.78 Million | ▼ -68.7% |
| 2022 | 0.32x | CN¥110.78 Million | CN¥35.88 Million | — |